antidepressants and semaglutide Computational phenotyping of effort-based decision-making in type-2 diabetes on off Semaglutide induces weight loss despite

You might not need to stop semaglutide altogether

A subgroup analysis by weight reduction iced the case for proportionate benefit of symptom relief and less inflammation (by biomarkers) as a function of weight loss These are striking results for people with HFpEf given the only other drugs that have thus far shown benefit are the sodium-glucose cotransporter 2 (SGLT2) inhibitors

Those with heart failure, kidney disease, or other conditions requiring fluid restriction should follow their healthcare provider's specific guidance

However, most insurance plans do not cover GLP-1 medications for weight loss as they consider obesity and overweight a cosmetic concern rather than a medical need